Page last updated: 2024-11-01

nitroglycerin and Pulmonary Disease, Chronic Obstructive

nitroglycerin has been researched along with Pulmonary Disease, Chronic Obstructive in 6 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
"The development of chronic obstructive pulmonary disease was associated with a paradoxical response of the dilatational component of vasoregulation against the background of increased constrictive influences of the vascular endothelium in the major and cerebral vessels."1.34Endothelial dysfunction of cerebral and major arteries during chronic obstructive disease. ( Agafonova, IG; Brodskaya, TA; Geltser, BI; Kotelnikov, VN; Lukyanov, PA, 2007)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Hodroge, SS1
Glenn, M1
Breyre, A1
Lee, B1
Aldridge, NR1
Sporer, KA1
Koenig, KL1
Gausche-Hill, M1
Salvucci, AA1
Rudnick, EM1
Brown, JF1
Gilbert, GH1
Johansson, MC1
Guron, CW1
Geltser, BI1
Brodskaya, TA1
Kotelnikov, VN1
Agafonova, IG1
Lukyanov, PA1
Routsi, C1
Stanopoulos, I1
Zakynthinos, E1
Politis, P1
Papas, V1
Zervakis, D1
Zakynthinos, S1
Marchetti, N1
Ciccolella, DE1
Jacobs, MR1
Crookshank, A1
Gaughan, JP1
Kashem, MA1
Bove, AA1
Criner, GJ1
McErlane, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT02412202]30 participants (Actual)Interventional2015-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

6 other studies available for nitroglycerin and Pulmonary Disease, Chronic Obstructive

ArticleYear
Adult Patients with Respiratory Distress: Current Evidence-based Recommendations for Prehospital Care.
    The western journal of emergency medicine, 2020, Jun-25, Volume: 21, Issue:4

    Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; California; Dyspnea; Emergency Medical Services; Ho

2020
Leftward bulging of atrial septum is provoked by nitroglycerin and by sustained valsalva strain.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2014, Volume: 27, Issue:10

    Topics: Aged; Atrial Pressure; Atrial Septum; Female; Humans; Male; Middle Aged; Nitroglycerin; Pulmonary Di

2014
Endothelial dysfunction of cerebral and major arteries during chronic obstructive disease.
    Bulletin of experimental biology and medicine, 2007, Volume: 144, Issue:6

    Topics: Acetylcholine; Animals; Carotid Arteries; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Mid

2007
Nitroglycerin can facilitate weaning of difficult-to-wean chronic obstructive pulmonary disease patients: a prospective interventional non-randomized study.
    Critical care (London, England), 2010, Volume: 14, Issue:6

    Topics: Aged; Female; Hemodynamics; Humans; Male; Nitroglycerin; Prospective Studies; Pulmonary Disease, Chr

2010
Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation.
    COPD, 2011, Volume: 8, Issue:2

    Topics: Aged; Aged, 80 and over; Brachial Artery; Disease Progression; Female; Forced Expiratory Volume; Hos

2011
Keeping track of the patch: transdermal delivery in obese patients.
    The American journal of nursing, 2005, Volume: 105, Issue:6

    Topics: Administration, Cutaneous; Angina Pectoris; Diabetes Mellitus, Type 2; Female; Humans; Middle Aged;

2005